Airway reopening mechanics depend on surfactant physicochemical properties. During reopening, the progression of a finger of air down an airway creates an interface that is continually expanding into the bulk fluid. Conventional surfactometers are not capable of evaluating physicochemical behavior under these conditions. To study these aspects, we investigated the pressure required to push a se...

In pulmonary tuberculosis, Mycobacterium tuberculosis bacteria reside in the alveoli and are in close proximity with the alveolar surfactant. Mycolic acid in its free form and as cord factor, constitute the major lipids of the mycobacterial cell wall. They can detach from the bacteria easily and are known to be moderately surface active. We hypothesize that these surface-active mycobacterial ce...

AIM To demonstrate the effects of combined inhaled nitric oxide and surfactant replacement as treatment for acute respiratory distress syndrome. This treatment has not previously been documented for reperfusion injury after double lung transplantation. METHOD A 24-year-old female with cystic fibrosis underwent double lung transplantation. During implantation of the second lung a marked increa...

Pulmonary surfactant lowers surface tension in the lungs. Physiological studies indicate two key aspects of this function: that the surfactant film forms rapidly; and that when compressed by the shrinking alveolar area during exhalation, the film reduces surface tension to very low values. These observations suggest that surfactant vesicles adsorb quickly, and that during compression, the adsor...

Naturally prepared radiolabelled pulmonary surfactant can be rapidly cleared from the alveolar surface to the lung tissue after intratracheal instillation into experimental rats. This clearance is both time- and dose-dependent, a large dose (10 mg/animal) becoming associated with lung tissue more rapidly than a smaller more physiological dose (0.75 mg/animal). The data indicate that extracellul...

The acute respiratory distress syndrome (ARDS) is characterized by arterial hypoxemia accompanied by severe inflammation and alterations to the pulmonary surfactant system. Published data has demonstrated a protective effect of matrix metalloproteinase-3 (Mmp3) deficiency against the inflammatory response associated with ARDS; however, the effect of Mmp3 on physiologic parameters and alteration...

Idiopathic pulmonary fibrosis is an intractable disease with a median survival time of 2 to 3 years. Serum levels of Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and surfactant protein D (SP-D) are useful biomarkers for idiopathic pulmonary fibrosis and they are widely used in Japan. Based on clinical use in Japan, a combination of KL-6, SPA, and SP-D is useful at diagnosing inte...

Alveolar membrane stability can be studied by finding out pulmonary surfactant activity (4, 5). Local anaesthetics possess the membrane stabilzing activity. Protective effect of propranolol against adrenaline induced pulmonary edema (APE) has been reported (6, 7). It has been proposed that it may be due to its local anaesthetic acti vity (7), but no experimental evidence was provided. Hence, pr...

Acute respiratory distress syndrome (ARDS) induced by lipopolysaccharide (LPS) is known to be associated with pulmonary cytokine production resulting in infiltration of neutrophils and pulmonary injury. The study presented here is focused on the changes in cell death regulating proteins during lung injury and studied the relationship between the LPS challenged ARDS and the subsequent role of su...

The methodology combining Axisymmetric Drop Shape Analysis (ADSA) with a captive bubble (ADSA-CB) facilitates pulmonary surfactant related studies. The accuracy of ADSA-CB is crucially dependent on the quality of the bubble profile extracted from the raw image. In a previous paper, an image analysis scheme featuring a Canny edge detector and a Axisymmetric Liquid Fluid Interfaces-Smoothing (ALF...